Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05592366 · ClinicalTrials.gov registry record · NA

Dementia Care Partner Hospital Assessment Tool

A NA study of Alzheimer Disease and Dementia, sponsored by University of Wisconsin, Madison.

Recruiting
Registry status
NA
Development phase
128
Enrollment target
1
Study location

NCT05592366 is a NA study of Alzheimer Disease and Dementia that is actively recruiting participants, run by University of Wisconsin, Madison. The registered enrollment target is 128 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05592366, a NA study of Alzheimer Disease and Dementia, is actively recruiting participants, sponsored by University of Wisconsin, Madison.

RECRUITING
Registry status
NA
Development phase
128 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they go home from the hospital. Participants will be a care partner ('family member or friend') who provides unpaid care to a hospitalized adult relative or partner to help them take care of themselves because of dementia. Participants can expect to be in this study for 14 days.

Interventions

  • BEHAVIORAL Care Partner Hospital Assessment Tool

Study Locations (1)

Wisconsin

  • University of Wisconsin - Madison

Trial Details

FieldValue
Enrollment Target 128 participants
Start Date 2024-04-02
Est. Completion 2027-05
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT05592366

The ClinicalTrials.gov registry entry for NCT05592366 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (95% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 1 intervention - of which Care Partner Hospital Assessment Tool is the first listed.

NCT05592366 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.

Frequently Asked Questions

What is clinical trial NCT05592366 about?

NCT05592366 is a clinical study titled "Dementia Care Partner Hospital Assessment Tool". The purpose of this study is to see whether an adapted questionnaire called the Care Partner Hospital Assessment Tool (CHAT) for care partners of hospitalized patients living with Alzheimer's disease and related dementias (ADRD) (CHAT-AD) can help people with dementia receive better care after they ...

What is the current status of trial NCT05592366?

This trial is currently recruiting. It is a NA study. The enrollment target is 128 participants. The study started on 2024-04-02. Estimated completion is 2027-05.

What conditions does trial NCT05592366 study?

This clinical trial studies the following conditions: Alzheimer Disease, Dementia.

What interventions are being tested in trial NCT05592366?

The interventions under investigation include: Care Partner Hospital Assessment Tool (BEHAVIORAL).

Who is sponsoring clinical trial NCT05592366?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05592366 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.